Novo Nordisk has tested a more effective weight loss treatment

Date:

Share this article:

Del denne artikel:

A large-scale trial of a new combination drug for type 2 diabetes may influence future treatment options.

Novo Nordisk has applied for approval in the United States for the drug CagriSema as a weight loss treatment in combination with diet and exercise.

If approved, it could be used in the same way as Wegovy.

At the same time, the company plans to test the medication against tirzepatide from Eli Lilly.

The market for this type of treatment is developing rapidly, with several companies competing to produce the most effective drugs.

Also read: Trump’s preferred sport is shared with his granddaughter Kai

The results come from the phase 3 trial REIMAGINE 2, which has not yet been published in a scientific journal, according to Medical News Today.

Results from the study

The trial included 2,728 people with type 2 diabetes who had not achieved sufficient results with metformin.

At the start, participants had an average long-term blood sugar (HbA1c) level of 8.2 percent and an average weight of 101 kilograms.

Over 68 weeks, participants received either CagriSema, the individual components administered separately, or a placebo.

Also read: Actor’s death brings renewed focus to colorectal cancer symptoms

According to Novo Nordisk’s data reported by Medical News Today, long-term blood sugar levels decreased by 1.91 percentage points in those who received the highest dose of CagriSema.

Among those who received semaglutide alone, the reduction was 1.76 percentage points.

Body weight decreased by an average of 14.2 percent with CagriSema, compared with 10.2 percent with semaglutide alone.

What does the medication contain?

CagriSema combines semaglutide and cagrilintide. Both substances affect hormones that regulate appetite, satiety, and blood sugar levels.

Also read: New research: Bedroom temperature affects the heart

An independent expert interviewed by Medical News Today emphasized that the results come from the manufacturer itself.

Further independent studies are therefore needed to assess effectiveness and side effects.

Only with additional documentation will it be possible to determine whether the treatment is genuinely superior to current options.

Sources: Medical News Today.

Also read: Doctor reveals when you should stop drinking coffee to sleep better

Also read: No gym required: Nine cardio exercises you can do at home

This article is made and published by Ida-Marie Palm Varbæk, who may have used AI in the preparation.

Other articles

How eating cabbage every day can affect your gut, heart and brain

Cabbage rarely gets health headlines, but the evidence for it is more solid than most people think.

How eating Greek yogurt every day can affect your gut, bones and weight

Strained, thick and unusually protein-dense, Greek yogurt is not just a fad. Here is what research suggests it may do for your gut, bones and weight.

Going completely sugar-free may backfire for your gut, early research warns

In a 16-week mouse study, no sucrose meant worse blood sugar and gut health.

8 warning signs of COPD that appear years before most people are ever diagnosed

Roughly 16 million Americans have been diagnosed, and millions more have no idea.

How eating cabbage every day can affect your gut, heart and brain

Cabbage rarely gets health headlines, but the evidence for it is more solid than most people think.

How eating Greek yogurt every day can affect your gut, bones and weight

Strained, thick and unusually protein-dense, Greek yogurt is not just a fad. Here is what research suggests it may do for your gut, bones and weight.

Going completely sugar-free may backfire for your gut, early research warns

In a 16-week mouse study, no sucrose meant worse blood sugar and gut health.